skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: Index New Zealand (Open Access) remove Database: Taylor & Francis Open Access remove top level: Digital Resources/Online E-Resources remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
Material Type:
Article 		Add to My Research

Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

Biologics, 2012-01, Vol.6 (default), p.201-206 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Cantini et al, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s31145 ;PMID: 22904612

Full text available

Citations Cited by
2
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma

Biologics, 2016-01, Vol.10, p.139-147 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Chávez-López et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S87402 ;PMID: 27703327

Full text available

Citations Cited by
3
Bevacizumab in the treatment of ovarian cancer
Bevacizumab in the treatment of ovarian cancer
Material Type:
Article 		Add to My Research

Bevacizumab in the treatment of ovarian cancer

Biologics, 2011-01, Vol.5 (default), p.1-5 [Peer Reviewed Journal]

2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Eskander and Randall, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S13071 ;PMID: 21383911

Full text available

Citations Cited by
4
Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
Material Type:
Article 		Add to My Research

Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis

Biologics, 2012-01, Vol.6 (default), p.31-35 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Hasan et al, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S27840 ;PMID: 22355257

Full text available

Citations Cited by
5
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
Material Type:
Article 		Add to My Research

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab

Biologics, 2012-01, Vol.6 (default), p.83-87 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Lurati et al, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S29079 ;PMID: 22532776

Full text available

Citations Cited by
6
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
Material Type:
Article 		Add to My Research

Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease

Biologics, 2008-01, Vol.2 (4), p.823-843 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3770 ;PMID: 19707461

Full text available

Citations Cited by
7
Emerging role of multikinase inhibitors for refractory thyroid cancer
Emerging role of multikinase inhibitors for refractory thyroid cancer
Material Type:
Article 		Add to My Research

Emerging role of multikinase inhibitors for refractory thyroid cancer

Biologics, 2012-01, Vol.6 (default), p.257-265 [Peer Reviewed Journal]

COPYRIGHT 2012 Dove Medical Press Limited ;2012. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Perez et al, publisher and licensee Dove Medical Press Ltd. 2012 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S24465 ;PMID: 22904617

Full text available

Citations Cited by
8
Mycophenolate mofetil in the treatment of lupus nephritis
Mycophenolate mofetil in the treatment of lupus nephritis
Material Type:
Article 		Add to My Research

Mycophenolate mofetil in the treatment of lupus nephritis

Biologics, 2008-06, Vol.2 (2), p.297-310 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s2266 ;PMID: 19707362

Full text available

Citations Cited by
9
Severe congenital protein C deficiency : the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
Severe congenital protein C deficiency : the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
Material Type:
Article 		Add to My Research

Severe congenital protein C deficiency : the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications

Biologics, 2008-06, Vol.2 (2), p.285-296 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s1954 ;PMID: 19707361

Full text available

Citations Cited by
10
Safety of etanercept in elderly subjects with rheumatoid arthritis
Safety of etanercept in elderly subjects with rheumatoid arthritis
Material Type:
Article 		Add to My Research

Safety of etanercept in elderly subjects with rheumatoid arthritis

Biologics, 2010-01, Vol.4 (default), p.1-4 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Lurati et al, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S5492 ;PMID: 20161980

Full text available

Citations Cited by
11
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer
The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer
Material Type:
Article 		Add to My Research

The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer

Biologics, 2008-01, Vol.2 (4), p.725-732 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Matsuyama and Yoshimura, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s3151 ;PMID: 19707453

Full text available

Citations Cited by
12
IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
Material Type:
Article 		Add to My Research

IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts

Biologics, 2008-09, Vol.2 (3), p.583-591 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Tamby et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3188 ;PMID: 19707389

Full text available

Citations Cited by
13
Rituximab therapy in Greek patients with rheumatoid arthritis
Rituximab therapy in Greek patients with rheumatoid arthritis
Material Type:
Article 		Add to My Research

Rituximab therapy in Greek patients with rheumatoid arthritis

Biologics, 2008-01, Vol.2 (4), p.911-916 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Tsiakalos et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3939 ;PMID: 19707469

Full text available

Citations Cited by
14
Infliximab in the treatment of ankylosing spondylitis
Infliximab in the treatment of ankylosing spondylitis
Material Type:
Article 		Add to My Research

Infliximab in the treatment of ankylosing spondylitis

Biologics, 2007-01, Vol.1 (2), p.163-171 [Peer Reviewed Journal]

Copyright Taylor & Francis Ltd. 2007 ;2007 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;PMID: 19707326

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2007  (1)
  2. 2007 To 2007  (1)
  3. 2008 To 2009  (6)
  4. 2010 To 2011  (2)
  5. After 2011  (5)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait